Literature DB >> 8609784

Presenilin-1 polymorphism and Alzheimer's disease.

W K Scott, J H Growdon, A D Roses, J L Haines, M A Pericak-Vance.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609784

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Clinical rationale of genetic testing in dementia.

Authors:  G B Frisoni; M Trabucchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

2.  Presenilin-1-immunoreactive neurons are preserved in late-onset Alzheimer's disease.

Authors:  P Giannakopoulos; C Bouras; E Kövari; J Shioi; N Tezapsidis; P R Hof; N K Robakis
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 3.  Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator.

Authors:  R Katzman; D Kang; R Thomas
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

4.  Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease.

Authors:  M Yasuda; N Hirono; K Maeda; T Imamura; E Mori; C Tanaka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

5.  Combined association of Presenilin-1 and Apolipoprotein E polymorphisms with maternal meiosis II error in Down syndrome births.

Authors:  Pranami Bhaumik; Priyanka Ghosh; Sujay Ghosh; Eleanor Feingold; Umut Ozbek; Biswanath Sarkar; Subrata Kumar Dey
Journal:  Genet Mol Biol       Date:  2017-07-31       Impact factor: 1.771

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.